With the rapid advancement of precision medicine, programmed cell death‐ligand 1 (PD‐L1) expression status in tumor cells has been attracting attention for its relation to the prognostic outcomes associated with EGFR‐TKIs in patients with EGFR‐mutated NSCLC. Here, EGFR is linked to neoplasm.